Have a personal or library account? Click to login
The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to tyrosine-kinase inhibitors in patients with metastatic primary renal cell carcinoma Cover

The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to tyrosine-kinase inhibitors in patients with metastatic primary renal cell carcinoma

Radiology and Oncology
Volume 48 (2014): Issue 3 (September 2014)
By: Carmelo Caldarella,  Barbara Muoio,  Maria Antonietta Isgrò,  Emilio Porfiri,  Giorgio Treglia and  Luca Giovanella  
Open Access
|Jul 2014

Authors

Carmelo Caldarella

carmelocaldarella@yahoo.it

Barbara Muoio

Maria Antonietta Isgrò

Emilio Porfiri

Giorgio Treglia

Luca Giovanella

DOI: https://doi.org/10.2478/raon-2013-0067 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 219 - 227
Submitted on: Feb 8, 2013
|
Accepted on: Aug 21, 2013
|
Published on: Jul 10, 2014
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
fluorodeoxyglucose,
positron emission tomography,
advanced renal cell carcinoma,
tyrosine-kinase inhibitors,
response to treatment
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2014 Carmelo Caldarella, Barbara Muoio, Maria Antonietta Isgrò, Emilio Porfiri, Giorgio Treglia, Luca Giovanella, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 48 (2014): Issue 3 (September 2014)Next article